| Dr Mohammed Hisham Obeidin, MD | |
|
1010 Prince Ave Ste 400, Athens, GA 30606-5805 | |
| (706) 425-1400 | |
| (706) 548-0184 |
| Full Name | Dr Mohammed Hisham Obeidin |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 51 Years |
| Location | 1010 Prince Ave Ste 400, Athens, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104987056 | NPI | - | NPPES |
| 000535972A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 036838 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Athens Specialty Care Llc | 8820349772 | 99 |
News Archive
As part of the U.S. Food and Drug Administration's continuing efforts to protect consumers from potentially dangerous or subpotent hand sanitizers, the agency has placed all alcohol-based hand sanitizers from Mexico on a countrywide import alert to help stop products that appear to be in violation from entering the U.S. until the agency is able to review the products' safety.
Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that it has initiated a Phase 2 clinical trial to evaluate PRM-151, its lead product candidate, in patients with myelofibrosis.
Researchers at the University of California, San Diego School of Medicine have used genetic engineering of human induced pluripotent stem cells to specifically and precisely parse the roles of a key mutated protein in causing familial Alzheimer's disease, discovering that simple loss-of-function does not contribute to the inherited form of the neurodegenerative disorder.
Children born with heart disease have an increased risk of developing type 2 diabetes after age 30, according to a new study.
A health reform fix-it bill by Senator Dianne Feinstein that was debated in a Senate committee this morning aims at closing what Feinstein called an "enormous loophole" in the new federal law, allowing insurers to jack up rates on insurance policies that Americans will soon be required to buy.
› Verified 4 days ago
| Entity Name | Athens Regional Specialty Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083939136 PECOS PAC ID: 8325162340 Enrollment ID: O20100827000645 |
News Archive
As part of the U.S. Food and Drug Administration's continuing efforts to protect consumers from potentially dangerous or subpotent hand sanitizers, the agency has placed all alcohol-based hand sanitizers from Mexico on a countrywide import alert to help stop products that appear to be in violation from entering the U.S. until the agency is able to review the products' safety.
Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that it has initiated a Phase 2 clinical trial to evaluate PRM-151, its lead product candidate, in patients with myelofibrosis.
Researchers at the University of California, San Diego School of Medicine have used genetic engineering of human induced pluripotent stem cells to specifically and precisely parse the roles of a key mutated protein in causing familial Alzheimer's disease, discovering that simple loss-of-function does not contribute to the inherited form of the neurodegenerative disorder.
Children born with heart disease have an increased risk of developing type 2 diabetes after age 30, according to a new study.
A health reform fix-it bill by Senator Dianne Feinstein that was debated in a Senate committee this morning aims at closing what Feinstein called an "enormous loophole" in the new federal law, allowing insurers to jack up rates on insurance policies that Americans will soon be required to buy.
› Verified 4 days ago
| Entity Name | Piedmont Athens Hospitalist Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578079000 PECOS PAC ID: 6305196411 Enrollment ID: O20180911003967 |
News Archive
As part of the U.S. Food and Drug Administration's continuing efforts to protect consumers from potentially dangerous or subpotent hand sanitizers, the agency has placed all alcohol-based hand sanitizers from Mexico on a countrywide import alert to help stop products that appear to be in violation from entering the U.S. until the agency is able to review the products' safety.
Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that it has initiated a Phase 2 clinical trial to evaluate PRM-151, its lead product candidate, in patients with myelofibrosis.
Researchers at the University of California, San Diego School of Medicine have used genetic engineering of human induced pluripotent stem cells to specifically and precisely parse the roles of a key mutated protein in causing familial Alzheimer's disease, discovering that simple loss-of-function does not contribute to the inherited form of the neurodegenerative disorder.
Children born with heart disease have an increased risk of developing type 2 diabetes after age 30, according to a new study.
A health reform fix-it bill by Senator Dianne Feinstein that was debated in a Senate committee this morning aims at closing what Feinstein called an "enormous loophole" in the new federal law, allowing insurers to jack up rates on insurance policies that Americans will soon be required to buy.
› Verified 4 days ago
| Entity Name | Piedmont Athens Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184130627 PECOS PAC ID: 8820349772 Enrollment ID: O20180917001273 |
News Archive
As part of the U.S. Food and Drug Administration's continuing efforts to protect consumers from potentially dangerous or subpotent hand sanitizers, the agency has placed all alcohol-based hand sanitizers from Mexico on a countrywide import alert to help stop products that appear to be in violation from entering the U.S. until the agency is able to review the products' safety.
Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that it has initiated a Phase 2 clinical trial to evaluate PRM-151, its lead product candidate, in patients with myelofibrosis.
Researchers at the University of California, San Diego School of Medicine have used genetic engineering of human induced pluripotent stem cells to specifically and precisely parse the roles of a key mutated protein in causing familial Alzheimer's disease, discovering that simple loss-of-function does not contribute to the inherited form of the neurodegenerative disorder.
Children born with heart disease have an increased risk of developing type 2 diabetes after age 30, according to a new study.
A health reform fix-it bill by Senator Dianne Feinstein that was debated in a Senate committee this morning aims at closing what Feinstein called an "enormous loophole" in the new federal law, allowing insurers to jack up rates on insurance policies that Americans will soon be required to buy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mohammed Hisham Obeidin, MD 1010 Prince Ave Ste 400, Athens, GA 30606-5805 Ph: (706) 425-1400 | Dr Mohammed Hisham Obeidin, MD 1010 Prince Ave Ste 400, Athens, GA 30606-5805 Ph: (706) 425-1400 |
News Archive
As part of the U.S. Food and Drug Administration's continuing efforts to protect consumers from potentially dangerous or subpotent hand sanitizers, the agency has placed all alcohol-based hand sanitizers from Mexico on a countrywide import alert to help stop products that appear to be in violation from entering the U.S. until the agency is able to review the products' safety.
Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that it has initiated a Phase 2 clinical trial to evaluate PRM-151, its lead product candidate, in patients with myelofibrosis.
Researchers at the University of California, San Diego School of Medicine have used genetic engineering of human induced pluripotent stem cells to specifically and precisely parse the roles of a key mutated protein in causing familial Alzheimer's disease, discovering that simple loss-of-function does not contribute to the inherited form of the neurodegenerative disorder.
Children born with heart disease have an increased risk of developing type 2 diabetes after age 30, according to a new study.
A health reform fix-it bill by Senator Dianne Feinstein that was debated in a Senate committee this morning aims at closing what Feinstein called an "enormous loophole" in the new federal law, allowing insurers to jack up rates on insurance policies that Americans will soon be required to buy.
› Verified 4 days ago
Dr. Thomas H Hawk Jr., M.D. Surgery Medicare: Medicare Enrolled Practice Location: 740 Prince Ave, Building 8a, Athens, GA 30606 Phone: 706-353-1630 Fax: 706-543-6825 | |
Dr. Earle Walcott Gunn Iii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 658 N. Chase Street, Ste 201, Athens, GA 30606 Phone: 706-353-2990 Fax: 706-353-2992 | |
Ashlee R Kimbrell, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 Prince Ave Ste 100, Athens, GA 30606 Phone: 706-425-1420 | |
Colby Canada, PA Surgery Medicare: Medicare Enrolled Practice Location: 1010 Prince Ave Ste 400, Athens, GA 30606 Phone: 706-425-1400 | |
Ryan M Katz, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Oglethorpe Ave Ste 2000, Athens, GA 30606 Phone: 706-548-5488 Fax: 706-548-0016 | |
Dr. Fia Yi, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3320 Old Jefferson Rd Ste 600, Athens, GA 30607 Phone: 706-353-2990 Fax: 706-353-2992 |